Transgenomic, a provider of genomics tools, prices above the original range of $12 - $14, at $15; for trading Tuesday.

Transgenomic (TBIO), a provider of DNA separation and genetic variation analysis research tools, software, reagents, prices 4.480mm shares at $15. The original terms were 4mm shares between $12 - $14. The lead underwriter is Chase H&Q and shares will begin trading Tuesday.